Appareil pulmonaire
MARIPOSA (73841937NSC3003)
A Phase 3, Randomized Study of Amivantamab and Lazertinib Combination Therapy;Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients with;EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer;MARIPOSA
Paris
NICOLAS GIRARD